JH
Jason Haas
DELAYED 1 MONTH
Chief Financial Officer; Director
LIGAND PHARMACEUTICALS INC
Odyssey Therapeutics, Inc.
Filings
2
Companies
2
Latest
Jun 5, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
60
ODTXCLUSTER 3
Odyssey Therapeutics, Inc.
Jason Haas
Chief Financial Officer
Purchase
$20.0K
1,000 sh
May 12 12:32 AM
May 8, 2026